Skip to main content
Top
Published in: Lung 1/2020

01-02-2020 | Peripheral Arterial Disease | COPD

Risk of Readmission and Mortality Following Hospitalization with Hypercapnic Respiratory Failure

Authors: Amber J. Meservey, Michael C. Burton, Jeffrey Priest, Charlotte C. Teneback, Anne E. Dixon

Published in: Lung | Issue 1/2020

Login to get access

Abstract

Purpose

Hypercapnic respiratory failure (HRF) is a frequent cause of hospitalization and a common comorbidity in hospitalized patients. There are few studies addressing what factors might predict poor outcomes in this patient population. The purpose of the current study was to investigate characteristics and outcomes of patients hospitalized with HRF.

Methods

A study of patients ≥ 18 years admitted with HRF in a 1-year period. Patients with limited life expectancy related to other conditions, and those with a non-respiratory cause of HRF, were excluded.

Results

202 subjects met eligibility criteria: 24% had a diagnosis of obstructive sleep apnea, 6% obesity hypoventilation, 46% chronic obstructive pulmonary disease, and 10% asthma. Fifteen (7%) died during the index admission. Forty-one patients (23%) were readmitted within 30 days: peripheral vascular disease [adjusted odds ratio (aOR) 4.78, CI 1.45–15.74] and tachycardia (aOR 2.97, CI 1.22–7.26) were associated with an increased risk of readmission. Sixty-six patients (36%) died after discharge. Risk of death was increased in older patients (aOR 1.32, CI 1.13–1.54 per 5 years), those with peripheral vascular disease (aOR 12.56, CI 2.35–67.21), higher Charlson co-morbidity index (aOR 1.39, CI 1.09–1.76), use of home oxygen (aOR 4.03, CI 1.89–8.57), and those who had been readmitted (aOR 3.07, CI 1.46–6.43).

Conclusions

Hospitalization for HRF is associated with a high morbidity and mortality. Our observation that home oxygen use was associated with increased mortality suggests that oxygen use could be a risk factor for death in patients with HRF.
Literature
1.
go back to reference Adler D, Pepin JL, Dupuis-Lozeron E, Espa-Cervena K, Merlet-Violet R et al (2017) Comorbidities and subgroups of patients surviving severe acute hypercapnic respiratory failure in the intensive care unit. Am J Respir Crit Care Med 196(2):200–207CrossRef Adler D, Pepin JL, Dupuis-Lozeron E, Espa-Cervena K, Merlet-Violet R et al (2017) Comorbidities and subgroups of patients surviving severe acute hypercapnic respiratory failure in the intensive care unit. Am J Respir Crit Care Med 196(2):200–207CrossRef
2.
go back to reference Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR (2010) Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med 182(3):325–331CrossRef Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR (2010) Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med 182(3):325–331CrossRef
3.
go back to reference U.S.B.o.D. Collaborators, Mokdad AH, Ballestros K, Echko M, Glenn S et al (2018) The state of US health, 1990–2016: burden of diseases, injuries, and risk factors among US states. JAMA 319(14):1444–1472CrossRef U.S.B.o.D. Collaborators, Mokdad AH, Ballestros K, Echko M, Glenn S et al (2018) The state of US health, 1990–2016: burden of diseases, injuries, and risk factors among US states. JAMA 319(14):1444–1472CrossRef
4.
go back to reference Senaratna CV, Perret JL, Lodge CJ, Lowe AJ, Campbell BE et al (2017) Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev 34:70–81CrossRef Senaratna CV, Perret JL, Lodge CJ, Lowe AJ, Campbell BE et al (2017) Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev 34:70–81CrossRef
5.
go back to reference Iftikhar IH, Roland J (2018) Obesity hypoventilation syndrome. Clin Chest Med 39(2):427–436CrossRef Iftikhar IH, Roland J (2018) Obesity hypoventilation syndrome. Clin Chest Med 39(2):427–436CrossRef
6.
go back to reference Soler X, Gaio E, Powell FL, Ramsdell JW, Loredo JS et al (2015) High prevalence of obstructive sleep apnea in patients with moderate to severe chronic obstructive pulmonary disease. Ann Am Thorac Soc 12(8):1219–1225PubMedPubMedCentral Soler X, Gaio E, Powell FL, Ramsdell JW, Loredo JS et al (2015) High prevalence of obstructive sleep apnea in patients with moderate to severe chronic obstructive pulmonary disease. Ann Am Thorac Soc 12(8):1219–1225PubMedPubMedCentral
7.
go back to reference Ahmad N, Taithongchai A, Sadiq R, Mustfa N (2012) Acute hypercapnic respiratory failure (AHRF): looking at long-term mortality, prescription of long-term oxygen therapy and chronic non-invasive ventilation (NIV). Clin Med (Lond) 12(2):188 Ahmad N, Taithongchai A, Sadiq R, Mustfa N (2012) Acute hypercapnic respiratory failure (AHRF): looking at long-term mortality, prescription of long-term oxygen therapy and chronic non-invasive ventilation (NIV). Clin Med (Lond) 12(2):188
8.
go back to reference Chu CM, Chan VL, Lin AW, Wong IW, Leung WS et al (2004) Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 59(12):1020–1025CrossRef Chu CM, Chan VL, Lin AW, Wong IW, Leung WS et al (2004) Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 59(12):1020–1025CrossRef
9.
go back to reference Fazekas AS, Aboulghaith M, Kriz RC, Urban M, Breyer MK et al (2018) Long-term outcomes after acute hypercapnic COPD exacerbation: first-ever episode of non-invasive ventilation. Wien Klin Wochenschr 130(19–20):561–568CrossRef Fazekas AS, Aboulghaith M, Kriz RC, Urban M, Breyer MK et al (2018) Long-term outcomes after acute hypercapnic COPD exacerbation: first-ever episode of non-invasive ventilation. Wien Klin Wochenschr 130(19–20):561–568CrossRef
10.
go back to reference Simonds AK (2017) The road not taken: missed opportunities in managing acute exacerbations of hypercapnic respiratory failure. Am J Respir Crit Care Med 196(2):124–125CrossRef Simonds AK (2017) The road not taken: missed opportunities in managing acute exacerbations of hypercapnic respiratory failure. Am J Respir Crit Care Med 196(2):124–125CrossRef
11.
go back to reference Konishi M, Akiyama E, Suzuki H, Iwahashi N, Maejima N et al (2015) Hypercapnia in patients with acute heart failure. ESC Heart Fail 2(1):12–19CrossRef Konishi M, Akiyama E, Suzuki H, Iwahashi N, Maejima N et al (2015) Hypercapnia in patients with acute heart failure. ESC Heart Fail 2(1):12–19CrossRef
12.
go back to reference Laserna E, Sibila O, Aguilar PR, Mortensen EM, Anzueto A et al (2012) Hypocapnia and hypercapnia are predictors for ICU admission and mortality in hospitalized patients with community-acquired pneumonia. Chest 142(5):1193–1199CrossRef Laserna E, Sibila O, Aguilar PR, Mortensen EM, Anzueto A et al (2012) Hypocapnia and hypercapnia are predictors for ICU admission and mortality in hospitalized patients with community-acquired pneumonia. Chest 142(5):1193–1199CrossRef
13.
go back to reference Iqbal N, Irfan M, Zubairi ABS, Awan S, Khan JA (2017) Association of hypercapnia on admission with increased length of hospital stay and severity in patients admitted with community-acquired pneumonia: a prospective observational study from Pakistan. BMJ Open 7(6):e013924CrossRef Iqbal N, Irfan M, Zubairi ABS, Awan S, Khan JA (2017) Association of hypercapnia on admission with increased length of hospital stay and severity in patients admitted with community-acquired pneumonia: a prospective observational study from Pakistan. BMJ Open 7(6):e013924CrossRef
14.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRef
15.
go back to reference Quan H, Li B, Couris CM, Fushimi K, Graham P et al (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173(6):676–682CrossRef Quan H, Li B, Couris CM, Fushimi K, Graham P et al (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173(6):676–682CrossRef
16.
go back to reference Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N et al (2009) Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381CrossRef Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N et al (2009) Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381CrossRef
17.
go back to reference Hosmer DW, Lemeshow S, Sturdivant RX (2013) Applied logistic regression. Wiley series in probability and statistics, 3 edn. Wiley, HobokenCrossRef Hosmer DW, Lemeshow S, Sturdivant RX (2013) Applied logistic regression. Wiley series in probability and statistics, 3 edn. Wiley, HobokenCrossRef
18.
go back to reference Lemyze M, Taufour P, Duhamel A, Temime J, Nigeon O et al (2014) Determinants of noninvasive ventilation success or failure in morbidly obese patients in acute respiratory failure. PLoS ONE 9(5):e97563CrossRef Lemyze M, Taufour P, Duhamel A, Temime J, Nigeon O et al (2014) Determinants of noninvasive ventilation success or failure in morbidly obese patients in acute respiratory failure. PLoS ONE 9(5):e97563CrossRef
19.
go back to reference Goto T, Faridi MK, Gibo K, Toh S, Hanania NA et al (2017) Trends in 30-day readmission rates after COPD hospitalization, 2006–2012. Respir Med 30:92–97CrossRef Goto T, Faridi MK, Gibo K, Toh S, Hanania NA et al (2017) Trends in 30-day readmission rates after COPD hospitalization, 2006–2012. Respir Med 30:92–97CrossRef
20.
go back to reference Lau CS, Siracuse BL, Chamberlain RS (2017) Readmission after COPD exacerbation scale: determining 30-day readmission risk for COPD patients. Int J Chronic Obstr Pulm Dis 12:1891–1902CrossRef Lau CS, Siracuse BL, Chamberlain RS (2017) Readmission after COPD exacerbation scale: determining 30-day readmission risk for COPD patients. Int J Chronic Obstr Pulm Dis 12:1891–1902CrossRef
21.
go back to reference Angraal S, Khera R, Zhou S, Wang Y, Lin Z et al (2018) Trends in 30-day readmission rates for Medicare and non-Medicare patients in the era of the Affordable Care Act. Am J Med 131(11):1324–1331.e14CrossRef Angraal S, Khera R, Zhou S, Wang Y, Lin Z et al (2018) Trends in 30-day readmission rates for Medicare and non-Medicare patients in the era of the Affordable Care Act. Am J Med 131(11):1324–1331.e14CrossRef
22.
go back to reference Beuther DA, Sutherland ER (2007) Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 175(7):661–666CrossRef Beuther DA, Sutherland ER (2007) Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 175(7):661–666CrossRef
23.
go back to reference Garg J, Patel B, Chaudhary R, Shah M, Gupta R et al (2019) Predictors of 30-day readmissions after catheter ablation for atrial fibrillation in the USA. J Interv Card Electrophysiol 55(3):243–250CrossRef Garg J, Patel B, Chaudhary R, Shah M, Gupta R et al (2019) Predictors of 30-day readmissions after catheter ablation for atrial fibrillation in the USA. J Interv Card Electrophysiol 55(3):243–250CrossRef
24.
go back to reference Vidula MK, McCarthy CP, Butala NM, Kennedy KF, Wasfy JH et al (2018) Causes and predictors of early readmission after percutaneous coronary intervention among patients discharged on oral anticoagulant therapy. PLoS ONE 13(10):e0205457CrossRef Vidula MK, McCarthy CP, Butala NM, Kennedy KF, Wasfy JH et al (2018) Causes and predictors of early readmission after percutaneous coronary intervention among patients discharged on oral anticoagulant therapy. PLoS ONE 13(10):e0205457CrossRef
25.
go back to reference Kheirbek RE, Wojtusiak J, Vlaicu SO, Alemi F (2016) Lack of evidence for racial disparity in 30-day all-cause readmission rate for older US Veterans hospitalized with heart failure. Qual Manag Health Care 25(4):191–196CrossRef Kheirbek RE, Wojtusiak J, Vlaicu SO, Alemi F (2016) Lack of evidence for racial disparity in 30-day all-cause readmission rate for older US Veterans hospitalized with heart failure. Qual Manag Health Care 25(4):191–196CrossRef
26.
go back to reference Basnet S, Zhang M, Lesser M, Wolf-Klein G, Qiu G et al (2018) Thirty-day hospital readmission rate amongst older adults correlates with an increased number of medications, but not with Beers medications. Geriatr Gerontol Int 18(10):1513–1518CrossRef Basnet S, Zhang M, Lesser M, Wolf-Klein G, Qiu G et al (2018) Thirty-day hospital readmission rate amongst older adults correlates with an increased number of medications, but not with Beers medications. Geriatr Gerontol Int 18(10):1513–1518CrossRef
27.
go back to reference Murphy PB, Rehal S, Arbane G, Bourke S, Calverley PMA et al (2017) Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomized clinical trial. JAMA 317(21):2177–2186CrossRef Murphy PB, Rehal S, Arbane G, Bourke S, Calverley PMA et al (2017) Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomized clinical trial. JAMA 317(21):2177–2186CrossRef
28.
go back to reference Kohnlein T, Windisch W, Kohler D, Drabik A, Geiseler J et al (2014) Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med 2(9):698–705CrossRef Kohnlein T, Windisch W, Kohler D, Drabik A, Geiseler J et al (2014) Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med 2(9):698–705CrossRef
29.
go back to reference Abdo WF, Heunks LM (2012) Oxygen-induced hypercapnia in COPD: myths and facts. Crit Care 16(5):323CrossRef Abdo WF, Heunks LM (2012) Oxygen-induced hypercapnia in COPD: myths and facts. Crit Care 16(5):323CrossRef
Metadata
Title
Risk of Readmission and Mortality Following Hospitalization with Hypercapnic Respiratory Failure
Authors
Amber J. Meservey
Michael C. Burton
Jeffrey Priest
Charlotte C. Teneback
Anne E. Dixon
Publication date
01-02-2020
Publisher
Springer US
Published in
Lung / Issue 1/2020
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-019-00300-w

Other articles of this Issue 1/2020

Lung 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.